BUNKA CHRISTOPHER 4
4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
- Award
Stock Options
2021-06-08+23,334→ 56,001 totalExercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying)
Holdings
- 215,912(indirect: Private Holding Company)
common shares
- 273,543
common shares
- 32,667
Stock Options
Exercise: $5.83From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying) - 6,667(indirect: Private Holding Company)
Warrants
Exercise: $10.50From: 2020-05-06Exp: 2025-05-06→ Common Shares (6,667 underlying)